{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:08:24Z","timestamp":1793711304021,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Non-motor symptoms in Parkinson\u2019s disease (PD) can reduce quality of life and increase disability. This historical cohort study investigated how rehabilitation intensity influences non-motor symptoms. The primary outcomes were changes in non-motor symptoms in the short and medium term. Secondary outcomes were changes in disability burden, motor symptom severity, and freezing of gait after treatment. Measurements were taken before (T0) and after treatment (T1) and 6\u2009\u00b1\u20091 months after T1 (T2). According to total training duration, 24 patients with PD were assigned to High-Intensity Training group (HIT, 1800\u2009min) and 24 to Low-Intensity Training (LIT, less than 900\u2009minutes). At T1, only the HIT group showed clinically significant improvements in non-motor symptoms, which were maintained at T2. In contrast, the LIT group experienced worsening disability at follow-up. Multivariate analysis revealed training intensity and baseline disability as predictors of improvement. These findings support the benefits of high intensity exercise in PD management.<\/jats:p>","DOI":"10.1038\/s41531-025-01035-7","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T13:20:20Z","timestamp":1750425620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of an intensive outpatient rehabilitation on non-motor patients\u2019 reported outcomes in PD: the INTENSO study"],"prefix":"10.1038","volume":"11","author":[{"given":"Marianna","family":"Capecci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Andrenelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Lambertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bisoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Grugnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hibel","family":"Margherita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Ceravolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00415-012-6557-8","volume":"259","author":"A Antonini","year":"2012","unstructured":"Antonini, A. et al. The progression of non-motor symptoms in Parkinson\u2019s disease and their contribution to motor disability and quality of life. J. Neurol. 259, 2621\u20132631 (2012).","journal-title":"J. Neurol."},{"key":"1035_CR2","unstructured":"Parkinson\u2019s Disease in Adults: Diagnosis and Management. (National Institute for Health and Care Excellence (NICE), London, 2017)."},{"key":"1035_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi, K. et al. Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov. Disord. 34, 180\u2013198 (2019).","journal-title":"Mov. Disord."},{"key":"1035_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/mds.20793","volume":"21","author":"G Lagalla","year":"2006","unstructured":"Lagalla, G., Millevolte, M., Capecci, M., Provinciali, L. & Ceravolo, M. G. Botulinum toxin type A for drooling in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study. Mov. Disord. 21, 704\u2013707 (2006).","journal-title":"Mov. Disord."},{"key":"1035_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00415-009-0085-1","volume":"256","author":"G Lagalla","year":"2009","unstructured":"Lagalla, G., Millevolte, M., Capecci, M., Provinciali, L. & Ceravolo, M. G. Long-lasting benefits of botulinum toxin type B in Parkinson\u2019s disease-related drooling. J. Neurol. 256, 563\u2013567 (2009).","journal-title":"J. Neurol."},{"key":"1035_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3233\/JPD-140425","volume":"5","author":"G Lamotte","year":"2015","unstructured":"Lamotte, G. et al. Effects of endurance exercise training on the motor and non-motor features of Parkinson\u2019s disease: a review. J. Parkinsons Dis. 5, 21\u201341 (2015).","journal-title":"J. Parkinsons Dis."},{"key":"1035_CR7","first-page":"369","volume":"26","author":"M Al-Jarrah","year":"2010","unstructured":"Al-Jarrah, M., Jamous, M., Al Zailaey, K. & Bweir, S. O. Endurance exercise training promotes angiogenesis in the brain of chronic\/progressive mouse model of Parkinson\u2019s Disease. NeuroRehabilitation 26, 369\u2013373 (2010).","journal-title":"NeuroRehabilitation"},{"key":"1035_CR8","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S1474-4422(13)70123-6","volume":"12","author":"GM Petzinger","year":"2013","unstructured":"Petzinger, G. M. et al. Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson\u2019s disease. Lancet Neurol. 12, 716\u2013726 (2013).","journal-title":"Lancet Neurol."},{"key":"1035_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fpsyg.2012.00086","volume":"3","author":"AG Thomas","year":"2012","unstructured":"Thomas, A. G., Dennis, A., Bandettini, P. A. & Johansen-Berg, H. The effects of Aerobic activity on brain structure. Front. Psychol. 3, 86 (2012).","journal-title":"Front. Psychol."},{"key":"1035_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrn2298","volume":"9","author":"CH Hillman","year":"2008","unstructured":"Hillman, C. H., Erickson, K. I. & Kramer, A. F. Be smart, exercise your heart: exercise effects on brain and cognition. Nat. Rev. Neurosci. 9, 58\u201365 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"1035_CR11","first-page":"CD013856","volume":"1","author":"M Ernst","year":"2023","unstructured":"Ernst, M. et al. Physical exercise for people with Parkinson\u2019s disease: a systematic review and network meta-analysis. Cochrane Database Syst. Rev. 1, CD013856 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1035_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1836-9553(13)70141-3","volume":"59","author":"LO Lima","year":"2013","unstructured":"Lima, L. O., Scianni, A. & Rodrigues-de-Paula, F. Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson\u2019s disease: a systematic review. J. Physiother. 59, 7\u201313 (2013).","journal-title":"J. Physiother."},{"key":"1035_CR13","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1017\/S135561771600076X","volume":"22","author":"LJP Altmann","year":"2016","unstructured":"Altmann, L. J. P. et al. Aerobic exercise improves mood, cognition, and language function in Parkinson\u2019s disease: results of a controlled study. J. Int Neuropsychol. Soc. 22, 878\u2013889 (2016).","journal-title":"J. Int Neuropsychol. Soc."},{"key":"1035_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/NPT.0000000000000249","volume":"43","author":"MR Landers","year":"2019","unstructured":"Landers, M. R., Navalta, J. W., Murtishaw, A. S., Kinney, J. W. & Pirio Richardson, S. A high-intensity exercise boot camp for persons with Parkinson disease: A Phase II, pragmatic, randomized clinical trial of feasibility, safety, signal of efficacy, and disease mechanisms. J. Neurol. Phys. Ther. 43, 12\u201325 (2019).","journal-title":"J. Neurol. Phys. Ther."},{"key":"1035_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jns.2015.04.004","volume":"353","author":"A Uhrbrand","year":"2015","unstructured":"Uhrbrand, A., Stenager, E., Pedersen, M. S. & Dalgas, U. Parkinson\u2019s disease and intensive exercise therapy\u2013a systematic review and meta-analysis of randomized controlled trials. J. Neurol. Sci. 353, 9\u201319 (2015).","journal-title":"J. Neurol. Sci."},{"key":"1035_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cct.2013.06.002","volume":"36","author":"CG Moore","year":"2013","unstructured":"Moore, C. G. et al. Study in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humans. Contemp. Clin. Trials 36, 90\u201398 (2013).","journal-title":"Contemp. Clin. Trials"},{"key":"1035_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/jamaneurol.2017.3517","volume":"75","author":"M Schenkman","year":"2018","unstructured":"Schenkman, M. et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with De Novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol. 75, 219\u2013226 (2018).","journal-title":"JAMA Neurol."},{"key":"1035_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06703-0","volume":"23","author":"CG Patterson","year":"2022","unstructured":"Patterson, C. G. et al. Study in Parkinson\u2019s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials 23, 855 (2022).","journal-title":"Trials"},{"key":"1035_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12877-022-03510-9","volume":"22","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Efficacy and evaluation of therapeutic exercises on adults with Parkinson\u2019s disease: a systematic review and network meta-analysis. BMC Geriatr. 22, 813 (2022).","journal-title":"BMC Geriatr."},{"key":"1035_CR20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/PHM.0b013e31828cd254","volume":"92","author":"G Frazzitta","year":"2013","unstructured":"Frazzitta, G. et al. The beneficial role of intensive exercise on Parkinson disease progression. Am. J. Phys. Med Rehabil. 92, 523\u2013532 (2013).","journal-title":"Am. J. Phys. Med Rehabil."},{"key":"1035_CR21","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/jnnp-2017-316437","volume":"89","author":"D Ferrazzoli","year":"2018","unstructured":"Ferrazzoli, D. et al. Efficacy of intensive multidisciplinary rehabilitation in Parkinson\u2019s disease: a randomised controlled study. J. Neurol. Neurosurg. Psychiatry 89, 828\u2013835 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370, 1453\u20131457 (2007).","journal-title":"Lancet"},{"key":"1035_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri, K. R., Healy, D. G., Schapira, A. H. V. & National Institute for Clinical Excellence Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 5, 235\u2013245 (2006).","journal-title":"Lancet Neurol."},{"key":"1035_CR24","doi-asserted-by":"publisher","first-page":"7553","DOI":"10.3390\/ijerph18147553","volume":"18","author":"E Murawska-Cia\u0142owicz","year":"2021","unstructured":"Murawska-Cia\u0142owicz, E. et al. BDNF impact on biological markers of depression-role of physical exercise and training. Int J. Environ. Res Public Health 18, 7553 (2021).","journal-title":"Int J. Environ. Res Public Health"},{"key":"1035_CR25","doi-asserted-by":"publisher","first-page":"R372","DOI":"10.1152\/ajpregu.00525.2009","volume":"298","author":"T Seifert","year":"2010","unstructured":"Seifert, T. et al. Endurance training enhances BDNF release from the human brain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R372\u2013R377 (2010).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"1035_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/14737175.2022.2128768","volume":"22","author":"S Machado","year":"2022","unstructured":"Machado, S. et al. Clinical applications of exercise in Parkinson\u2019s disease: what we need to know?. Expert Rev. Neurother. 22, 771\u2013780 (2022).","journal-title":"Expert Rev. Neurother."},{"key":"1035_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40520-020-01612-1","volume":"33","author":"C Martignon","year":"2021","unstructured":"Martignon, C. et al. Guidelines on exercise testing and prescription for patients at different stages of Parkinson\u2019s disease. Aging Clin. Exp. Res 33, 221\u2013246 (2021).","journal-title":"Aging Clin. Exp. Res"},{"key":"1035_CR28","first-page":"291","volume":"35","author":"BM Morberg","year":"2014","unstructured":"Morberg, B. M., Jensen, J., Bode, M. & Wermuth, L. The impact of high intensity physical training on motor and non-motor symptoms in patients with Parkinson\u2019s disease (PIP): a preliminary study. NeuroRehabilitation 35, 291\u2013298 (2014).","journal-title":"NeuroRehabilitation"},{"key":"1035_CR29","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1016\/j.apmr.2018.05.007","volume":"99","author":"J Toll\u00e1r","year":"2018","unstructured":"Toll\u00e1r, J., Nagy, F., Kov\u00e1cs, N. & Hortob\u00e1gyi, T. A high-intensity multicomponent agility intervention improves Parkinson patients\u2019 clinical and motor symptoms. Arch. Phys. Med Rehabil. 99, 2478\u20132484.e1 (2018).","journal-title":"Arch. Phys. Med Rehabil."},{"key":"1035_CR30","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1007\/s13311-020-00904-8","volume":"17","author":"S Schootemeijer","year":"2020","unstructured":"Schootemeijer, S., van der Kolk, N. M., Bloem, B. R. & de Vries, N. M. Current perspectives on aerobic exercise in people with Parkinson\u2019s disease. Neurotherapeutics 17, 1418\u20131433 (2020).","journal-title":"Neurotherapeutics"},{"key":"1035_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18, 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1035_CR32","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.parkreldis.2015.09.005","volume":"22","author":"G Abbruzzese","year":"2016","unstructured":"Abbruzzese, G., Marchese, R., Avanzino, L. & Pelosin, E. Rehabilitation for Parkinson\u2019s disease: Current outlook and future challenges. Parkinsonism Relat. Disord. 22, S60\u2013S64 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1035_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","volume":"45","author":"M Hamon","year":"2013","unstructured":"Hamon, M. & Blier, P. Monoamine neurocircuitry in depression and strategies for new treatments. Prog. Neuropsychopharmacol. Biol. Psychiatry 45, 54\u201363 (2013).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1035_CR34","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1590\/S1516-31801998000100005","volume":"116","author":"RM Arida","year":"1998","unstructured":"Arida, R. M., Naffah-Mazzacoratti, M., da, G., Soares, J. & Cavalheiro, E. A. Monoamine responses to acute and chronic aerobic exercise in normotensive and hypertensive subjects. Sao Paulo Med. J. 116, 1618\u20131624 (1998).","journal-title":"Sao Paulo Med. J."},{"key":"1035_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0165-1781(92)90109-G","volume":"41","author":"G Gerra","year":"1992","unstructured":"Gerra, G. et al. ACTH and beta-endorphin responses to physical exercise in adolescent women tested for anxiety and frustration. Psychiatry Res. 41, 179\u2013186 (1992).","journal-title":"Psychiatry Res."},{"key":"1035_CR36","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/cercor\/bhn013","volume":"18","author":"H Boecker","year":"2008","unstructured":"Boecker, H. et al. The runner\u2019s high: opioidergic mechanisms in the human brain. Cereb. Cortex 18, 2523\u20132531 (2008).","journal-title":"Cereb. Cortex"},{"key":"1035_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1590\/S1807-59322005000100012","volume":"60","author":"MAM Peluso","year":"2005","unstructured":"Peluso, M. A. M. & Guerra de Andrade, L. H. S. Physical activity and mental health: the association between exercise and mood. Clinics. 60, 61\u201370 (2005).","journal-title":"Clinics."},{"key":"1035_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7260130","volume":"2017","author":"C Phillips","year":"2017","unstructured":"Phillips, C. Brain-derived neurotrophic factor, depression, and physical activity: making the neuroplastic connection. Neural Plast. 2017, 7260130 (2017).","journal-title":"Neural Plast."},{"key":"1035_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","volume":"38","author":"P Kowia\u0144ski","year":"2018","unstructured":"Kowia\u0144ski, P. et al. BDNF: A key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol. Neurobiol. 38, 579\u2013593 (2018).","journal-title":"Cell Mol. Neurobiol."},{"key":"1035_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/mds.27936","volume":"35","author":"C Cosentino","year":"2020","unstructured":"Cosentino, C. et al. Effectiveness of physiotherapy on freezing of gait in Parkinson\u2019s disease: a systematic review and meta-analyses. Mov. Disord. 35, 523\u2013536 (2020).","journal-title":"Mov. Disord."},{"key":"1035_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41531-021-00224-4","volume":"7","author":"M Gilat","year":"2021","unstructured":"Gilat, M. et al. A systematic review on exercise and training-based interventions for freezing of gait in Parkinson\u2019s disease. NPJ Parkinsons Dis. 7, 81 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"1035_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40734-015-0020-9","volume":"2","author":"G Frazzitta","year":"2015","unstructured":"Frazzitta, G. et al. Multidisciplinary intensive rehabilitation treatment improves sleep quality in Parkinson\u2019s disease. J. Clin. Mov. Disord. 2, 11 (2015).","journal-title":"J. Clin. Mov. Disord."},{"key":"1035_CR43","first-page":"125","volume":"45","author":"A Olivares","year":"2019","unstructured":"Olivares, A., Comini, L., Orfano, J., Froldi, M. & Vezzadini, G. Occupational therapy with Nordic walking and therapeutic touch: A pilot study for multidisciplinary rehabilitation in Parkinson\u2019s disease. NeuroRehabilitation 45, 125\u2013134 (2019).","journal-title":"NeuroRehabilitation"},{"key":"1035_CR44","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","volume":"22","author":"KR Chaudhuri","year":"2007","unstructured":"Chaudhuri, K. R. et al. The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: Results from an international pilot study. Mov. Disord. 22, 1901\u20131911 (2007).","journal-title":"Mov. Disord."},{"key":"1035_CR45","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"1035_CR46","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/app13021126","volume":"13","author":"M Capecci","year":"2023","unstructured":"Capecci, M. et al. Clinical and functional evolution in subjects with Parkinson\u2019s disease during SARS-CoV-2 pandemic. Appl. Sci. 13, 1126 (2023).","journal-title":"Appl. Sci."},{"key":"1035_CR47","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10072-014-2037-5","volume":"36","author":"N Tambasco","year":"2015","unstructured":"Tambasco, N. et al. The validation of an Italian version of the Freezing of Gait Questionnaire. Neurol. Sci. 36, 759\u2013764 (2015).","journal-title":"Neurol. Sci."},{"key":"1035_CR48","unstructured":"Riebe D., Ehrman J. K., Liguori G., Magal M, ACSM\u2019s guidelines for exercise testing and prescription. (2018)."},{"key":"1035_CR49","unstructured":"Walter Santilli. Linee Guida Ed Evidenze Scientifiche In Medicina Fisica E Riabilitativa. (Centro Stampa - Universit\u00e0 degli Studi di Roma \u201cLa Sapienza\u201d, 2017)."},{"key":"1035_CR50","unstructured":"Keus S. et al. European physiotherapy guideline for Parkinson\u2019s disease. (2014)."},{"key":"1035_CR51","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/mdc3.13262","volume":"8","author":"P Bugalho","year":"2021","unstructured":"Bugalho, P. et al. Progression in Parkinson\u2019s Disease: Variation In Motor And Non-motor Symptoms Severity And Predictors Of Decline In Cognition, Motor Function, Disability, And Health-related Quality Of Life As Assessed By Two Different Methods. Mov. Disord. Clin. Pr. 8, 885\u2013895 (2021).","journal-title":"Mov. Disord. Clin. Pr."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01035-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:03:28Z","timestamp":1750428208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01035-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01035-7","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"30 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}